Edwards Lifesciences Corporation
Donald E Bobo Jr (CVP,Strategy/Corp Development) sells EW shares
AI-generated summary
CVP,Strategy/Corp Development Donald E Bobo Jr exercised 48,900 options for $3,554,052 and sold 48,900 shares of common stock for $5,039,311 at an average price of $103.05. After these transactions, Donald E Bobo Jr directly held 22,798.2532 shares of common stock. The transactions were made under a Rule 10b5-1 trading plan adopted on February 12, 2026.
Key facts
- Insider
- Donald E Bobo Jr · CVP,Strategy/Corp Development
Rule 10b5-1 plan · adopted Feb 12, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +48,900 | $72.68 | $3,554,052.00 | 71,698.2532 | Direct |
| Nov 9, 2026 | S · open-market saleFootnotes F1, F2 | −48,900 | $103.05 | $5,039,311.26 | 22,798.2532 | Direct |
| Nov 9, 2026 | M · exercise or conversion of a derivativeEmployee Stock Option (Right to Acquire) | −48,900 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 12, 2026.
- F2 This transaction was executed in multiple trades at prices ranging from $103.00 to $103.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Remarks: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
More EW filings
- 4
Filed Nov 9, 2026
- 144
Filed Nov 9, 2026
- 144
Filed Nov 9, 2026
- 10-Q
Filed Nov 4, 2026
- 8-K
Filed Nov 4, 2026
- 4
Filed Oct 8, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.